| Literature DB >> 35403090 |
Smarajit Maiti1,2, Amrita Banerjee1, Mehak Kanwar1.
Abstract
Background SARS-CoV-2 claimed 5,209,104 lives, infected 260,997,910 individuals, globally. Infection is caused due to exposure or susceptibility; deaths occur due to age,comorbidity,higher-viral-load, immuno-suppression, inflammation, and multi-organ failure. Theaflavin-gallate, the major black tea component, showed previous evidence to inhibit HIV-1. Purpose As theaflavin-gallate prevents experimental rat-lung injury, the study of inhibitory effects of theaflavin-gallate was done, on SARS-CoV-2proteins and various host proteins related to some adverse effects in COVID-19 patients. Study Design Currently, some prospective phytochemical, black-tea (Camellia-sinensis) extract (BTE) was initially tested in vivo in strong oxidant-mutagen arsenic-induced model rat lung injury similar to that of COVID-19 manifestations like severe inflammation, oxidative stress, lung tissue degenerations, and apoptotic death. In silico, extensive bioinformatics and molecular docking experiments were performed on all catechin or theaflavin derivatives of C. sinensis, and finally theaflavin-3'-O-gallate (TFMG) were screened for blocking or inactivation of several proteins of SARS CoV-2 and host adversely-acting proteins or factors. Methods In vivo experiments in DNA stability (ladder, comet assay), free radicals attack (malondialdehyde; MDA, superoxide dismutase SOD, catalase gel-zymogram assay), extra cellular matrix damage (matrix metalloprotease; MMP2and9 zymogram assay) and inflammation (TNF-α, ELISA). In silico experiments- molecular docking by AutoDock-Patchdock analysis, Surface Topology Calculation by CASTp, Grid-value calculation, and Ramachandran Plot study. Results The BTE showed strong protection of lung DNA and cell-matrix by decreasing MMPs, TNF-α, and free radicals, the same factors affecting COVID-19 patients. In silico data suggest that TFMG significantly blocked the entry, exit, and amino acids at catalytic active-site of more than thirty proteins including viral (nsp1,nsp2,Mainpro,∼-9.0 kcal/mol) and host inflammatory, oxidants, apoptotic, vaso-destabilizer molecules (FAS, CD40R, BCL2, TLR2, ∼ -10 and ACE1or2 ∼ -9.0 and AT1or2∼ -7.5 kcal/mol and more). When the binding energy of TFMG ranged from -7 to -11.7 kcal/mol(average -9.0) the same for hydroxy‑Chloroquine ranged (-2.5 to -7 average -4.5) and dexamethasone (-3.0 to -6.0, average -4.0 kcal/mol). Conclusions TFMG has some novel physicochemical or structural properties like (ACE values of binding to all tested proteins, -300 to -625), (for TFMG H-bond acceptor or donor: 15/10, for TFDG 20/13). Their topological-polar-surface-area (264Ų and 351Ų) and travel depth/height; 17.0/9.6 Å and 15.4/11.3 Å, respectively) were more potent than other compounds. Conclusively, the efficacy of TFMG may be further verified.Entities:
Keywords: Active site docking; Global pandemic and SARS CoV-2; Inflammation and vaso-destabilizing proteins; Theaflavin mono gallate; Therapeutic intervention
Year: 2022 PMID: 35403090 PMCID: PMC8820952 DOI: 10.1016/j.phyplu.2022.100237
Source DB: PubMed Journal: Phytomed Plus ISSN: 2667-0313
Patchdock analysis data on TFMG docking on 31 proteins are presented.
| Name of the molecules | PDB/Uniprot ID | Best PatchDock Atomic Contact Energy Value (ACE) | Surface area |
|---|---|---|---|
| Viral proteins | |||
| C-terminus protease | QHD43415_5 | −531.35, −458.28, −436.10 | 733.30, 708.90, 800.00 |
| nsp2 | QHD43415_2 | −498.50, −487.90, −477.94 | 878.20, 758.80, 807.30 |
| N-terminus protease | QHD43415_3 | −383.73, −378.93, −376.85 | 744.30, 713.90, 770.70 |
| nucleocapsid | QHD43423 | −556.35, −273.85, −266.78 | 868.10, 706.00, 624.50 |
| COVID-19 main protease | 6LU7 | −383.73, −378.93, −376.85 | 744.30, 713.90, 770.70 |
| nCov2 Spike | 6svb | −434.42, −397.12, −392.53 | 906.20, 969.10, 911.40 |
| Human proteins | |||
| FAS_D | 3tje | −467.22, −400.62, −400.04 | 878.40, 797.50, 773.60 |
| CD40 | 6pe9 | −506.45, −475.73, −473.95 | 856.80, 933.20, 869.10 |
| CD40_R | 1aly | −353.37, −282.93, −244.56 | 696.80, 479.90, 588.90 |
| IL1R | 1itb | −333.00, −329.21, −303.53 | 761.80, 663.20, 763.20 |
| IL6R | 1p9m | −413.76, −355.92, −342.27 | 777.50, 672.30, 698.70 |
| TNFR1 | 1ncf | −412.25, −351.30, −324.34 | 660.80, 673.50, 646.60 |
| TNFR2 | 3alq | −199.59, −190.95, −153.60 | 732.60, 666.30, 668.00 |
| IFNϒ | 1fg9 | −467.46, −430.45, −389.77 | 830.50, 861.00, 701.90 |
| TNFa | 1tnf | −456.27, −323.00, −317.63 | 729.20, 810.70, 650.80 |
| Bcl2 | 4ieh | −309.63, −265.62, −258.02 | 712.50, 784.60, 629.50 |
| Bax | 4s0o | −474.43, −377.74, −346.51 | 773.40, 686.40, 814.80 |
| NFκβ | 1nfk | −397.99, −373.50, −312.99 | 780.50, 782.40, 753.30 |
| HIF1α | 4ajy | −446.61, −363.67, −342.04 | 609.80, 700.80, 530.80 |
| monomeric TLR2 | 2Z80 | −455.90, −321.99, −320.23 | 686.00, 525.40, 676.40 |
| dimeric TLR2 | 2Z80 | −155.51, −93.60, −91.630 | 936.60, 891.60, 794.00 |
| Monomeric TLR4 | 3fxi | −203.49, −137.48, −130.44 | 776.10, 690.50, 794.20 |
| MultimericTLR4 | 3fxi | −489.31, −456.83, −389.56 | 808.50, 740.20, 724.10 |
| Caspase3 | 1 gfw | −373.91, −356.51, −338.93 | 681.30, 780.90, 592.70 |
| Caspase 8 | 1f9e | −299.09, −239.61, −239.35 | 720.90, 738.00, 804.70 |
| MMP 2 | 3ayu | −616.95, −593.93, −583.02 | 734.70, 780.50, 736.00 |
| MMP9 | 2ow0 | −625.14, −614.45, −591.09 | 880.30, 948.20, 890.20 |
| ACE2 | 4aph | −319.12, −248.17, −229.89 | 911.90, 785.50, 891.90 |
| ACE1 | 6en5 | −351.19, −269.59, −226.69 | 717.00, 721.70, 724.10 |
| AT2 | 5xjm | −360.15, −343.08, −334.87 | 819.20, 700.90, 683.20 |
| AT1 | 6os1 | −378.52, −285.57, −282.28 | 741.40, 736.90, 853.90 |
Fig. 1AutoDock and/or Patchdock binding images of TFMG with viral proteins are presented. Yellow circle designate H- bonding. Amino acids demarcated in the active site locations and those participate with TFMG binding. Refer to supplementary-file.
Fig. 2AutoDock and/or Patchdock binding images of TFMG with host vasoactive proteins are presented. Yellow/red circle designate H- bonding. Amino acids demarcated in the active site locations and those participate with TFMG binding. Refer to supplementary file.
Fig. 3AutoDock and/or Patchdock binding images of TFMG with host immuno- suppressive and inflammatory stress proteins are presented. Yellow/red/blue circle designate H- bonding. Amino acids demarcated in the active site locations and those participate with TFMG binding. Refer to supplementary file.
Different molecular parameter analysis of used ligand molecules to predict their druggability.
| Name | Pubchem ID | Molecular Weight (g/mol) | H-bond | Rotatable Bond count | Topological Polar Surface Area (Ų) | Depth (Å) | Height (Å) | |
|---|---|---|---|---|---|---|---|---|
| Acceptor | Donor | |||||||
| Theaflavin-3′-O-gallate | 71,307,578 | 704.6 | 15 | 10 | 5 | 264 | 17.0 | 9.6 |
| Theaflavin 3,3′-digallate | 135,403,795 | 868.7 | 20 | 13 | 8 | 351 | 15.4 | 11.3 |
| (-)- Gallocatechin gallate | 199,472 | 458.4 | 11 | 8 | 4 | 197 | 14.5 | 8.3 |
| (-)-Epigallocatechin gallate | 65,064 | 458.4 | 11 | 8 | 4 | 197 | 11.5 | 8.3 |
| Epigallocatechin | 72,277 | 306.27 | 7 | 6 | 1 | 131 | 11.5 | 1.4 |
| Epigallocatechin-(4beta->8)-epicatechin-3-O-gallate | 442,678 | 746.6 | 17 | 13 | 6 | 308 | 10.4 | 8.3 |
| Hydroxychloroquine | 3652 | 335.9 | 4 | 2 | 9 | 48.4 | 8.9 | 6.8 |
| Dexamethasone | 5743 | 392.5 | 6 | 3 | 2 | 94.8 | 12.1 | 4.1 |
Fig. 4Protective effects of black tea extract (BTE) against arsenic induced rat lung injuries have been demonstrated. Black tea extract only (BTE) showed better Protective effects of DNA stability than that of control (a). BTE showed protection and/or strong restoration of SOD, catalase (b) and decreased free radical damage as MDA level (c). In arsenic induced model rat lung injury, it showed protection in DNA protection as lower number of comets (d). Matrix damaging MMP2and MMP9 was also decreased in BTE supplemented group than that of arsenic treated group (e). BTE showed strong anti-inflammatory effects by restoring the TNF-α compared to the arsenic treated group (f).